| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.88  |
1-year : | 3.28 |
| Resists | First : | 2.46 |
Second : | 2.8 |
| Pivot price | 2.12 |
|||
| Supports | First : | 1.9 | Second : | 1.58 |
| MAs | MA(5) : | 2.1 |
MA(20) : | 2.13 |
| MA(100) : | 2.27 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 22.5 |
D(3) : | 27.9 |
| RSI | RSI(14): 45.3 |
|||
| 52-week | High : | 3.09 | Low : | 1.07 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PRQR ] has closed above bottom band by 49.1%. Bollinger Bands are 21.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.15 - 2.16 | 2.16 - 2.17 |
| Low: | 1.94 - 1.95 | 1.95 - 1.96 |
| Close: | 2.1 - 2.12 | 2.12 - 2.14 |
Mon, 01 Dec 2025
ProQR to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewswire
Sat, 29 Nov 2025
Will PRQR stock deliver better than expected guidance - July 2025 Sector Moves & Verified Chart Pattern Signals - BỘ NỘI VỤ
Thu, 27 Nov 2025
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Mon, 24 Nov 2025
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 29% Share Price Plunge Could Signal Some Risk - Sahm
Thu, 06 Nov 2025
ProQR Announces Third Quarter 2025 Operating and Financial Results - GlobeNewswire
Thu, 06 Nov 2025
ProQR (NASDAQ: PRQR) Receives CTA for AX-0810 Phase 1; first safety/PK data by year-end - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 105 (M) |
| Shares Float | 65 (M) |
| Held by Insiders | 18 (%) |
| Held by Institutions | 50.1 (%) |
| Shares Short | 778 (K) |
| Shares Short P.Month | 2,090 (K) |
| EPS | -0.48 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.54 |
| Profit Margin | -264.9 % |
| Operating Margin | -387.2 % |
| Return on Assets (ttm) | -24.1 % |
| Return on Equity (ttm) | -103.8 % |
| Qtrly Rev. Growth | -26.8 % |
| Gross Profit (p.s.) | 0.15 |
| Sales Per Share | 0.15 |
| EBITDA (p.s.) | -0.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -49 (M) |
| Levered Free Cash Flow | -32 (M) |
| PE Ratio | -4.42 |
| PEG Ratio | 0 |
| Price to Book value | 3.92 |
| Price to Sales | 13.89 |
| Price to Cash Flow | -4.58 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|